GSK said on Friday the addition of its cancer drug Jemperli to both standard of care chemotherapy and Zejula maintenance ...

The rates of life-threatening breast cancer are spiking among women of all ages, with a significant increase in those under 40. A new study found that cases of metastatic breast cancer — in which ...

It's long been considered a disease for older people but research shows bowel cancer rates in young people are rising. And ...

These survivors, or “cancer thrivers” as some of us prefer to say, helped show me that metastatic cancer is no longer a death sentence.

A recent study reveals a concerning rise in late-stage breast cancer diagnoses, especially among younger (20-39) and older (75+) women. Black women are disproportionately affected, facing a 55% ...

The immunotherapy, CAN-2409, in combination with radiation therapy, helped 75.2% patients live without any sign of the cancer ...

Pressure is building on health service decision-makers to take action on prostate cancer screening. Prostate Cancer Research ...

with non-small cell lung cancer (NSCLC) the most prevalent. Unfortunately, patients in Puerto Rico were diagnosed at late stages (stages III/IV), and received platinum-based systemic therapy as ...

That compares to the 65.7% patients who received only radiation in the late-stage trial, which enrolled 745 participants. More than 100,000 men are diagnosed with prostate cancer every year in the ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

The new test works by shining a laser beam into the patient's blood plasma, then using AI to interpret the results - with ...

OSE Immunotherapeutics Announces Positive Clinical Progress for Late-Stage Proprietary Cancer Vaccine Tedopi® ...